Regeneron Pharmaceuticals | REGN - Le Revenu D'Intérêts





Le Revenu D'Intérêts Changement Date
AbbVie USD 59M 13M 2025-12
Agios Pharmaceuticals USD 12.41M 959K 2025-12
Alnylam Pharmaceuticals USD 26.63M 2.05M 2025-12
Astellas Pharma JPY 4.12B 2.94B 2024-03
AstraZeneca USD 73M 62M 2026-03
Biogen USD 37.9M 700K 2026-03
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Eli Lilly USD 65M 25M 2025-09
Esperion Therapeutics USD -0.15 0.18 2024-09
Gilead Sciences USD 95M 7M 2025-12
GlaxoSmithKline GBP 22M 96M 2026-03
Incyte USD 33.69M 2.93M 2026-03
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
J&J USD 2.14 237M 2026-03
Kyowa Hakko Kirin JPY 2.54B 1.52B 2024-06
Merck USD 69M 27M 2025-12
Moderna USD 70M 3M 2025-12
Pfizer USD 115M 51M 2026-03
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 193.3M 18.2M 2025-12
Sanofi EUR 114M 38M 2025-09
Sarepta Therapeutics USD 8.74M 359K 2025-12
Ultragenyx Pharmaceutical USD 6.51M 649K 2025-12
United Therapeutics USD 43.2M 3.2M 2025-12
Vertex Pharmaceuticals USD 114.8M 7.1M 2026-03